Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
07/2004
07/01/2004WO2004012656A3 Thiophene and furan derivatives as prostaglandin agonists and use thereof
07/01/2004WO2003080577A3 Amidoacetonitrile compounds
07/01/2004WO2003045878A8 2,w-diaminocarboxylic acid compounds
07/01/2004US20040127744 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents
07/01/2004US20040127728 condensation; reduction; catalytic hydrogenation
07/01/2004US20040127726 Method for purifying an organic solvent for the purposes of absorption of maleic acid anhydride
07/01/2004US20040127724 such as 3-aminomethyl-4-thiophen-2-yl-butyric acid; for treating epilepsy, neurodegenerative disorders, depression, anxiety, panic, pain, irritable bowel syndrome, and arthritis
07/01/2004US20040127721 Process for the synthesis of bis-aryl diamidoxime compounds
07/01/2004US20040127720 comprises heterocyclic carbenes; recycling polester/polyamide wastes; by-product inhibition
07/01/2004US20040127689 activated haptens useful for generating immunogens to HIV protease inhibitors
07/01/2004US20040127576 Estrogen receptor modulators
07/01/2004US20040127549 Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases
07/01/2004US20040127546 for treating or preventing diabetes, obesity, hyperlipidemia, digestive diseases, depression or urinary disturbances; beta 3-agonist
07/01/2004US20040127513 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease
07/01/2004US20040127495 Preferential suppressors of immunoglobulins, used as immunosuppressants and antiallergens
07/01/2004US20040127494 Sulfur compounds such as (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide, used for prophylaxis of neurodegenarative disorders such as Alzheimer's Disease and Down's Syndrome
07/01/2004US20040127488 For therapy of HIV virus infection in a human
07/01/2004US20040127487 For therapy and prophylaxis of bone diseases, cancer, systemic granuloma, immunological diseases, allergy, atopy, asthma, gumboil, gingivitis, periodontitis, neurocyte death, Alzheimer's diseases, lungs injury, pulmopathy, acute hepatitis
07/01/2004US20040127464 potent, selective and safe inhibitors of the Ca2+-activated potassium channel
07/01/2004US20040127430 Chiral monophosphorus compounds and their transition metal complexes
07/01/2004US20040127424 Inhibitors of cruzipain and other cysteine proteases
07/01/2004US20040127365 Arylphenyl-substituted cyclic ketoenols
07/01/2004US20040124399 Enantiomorph mixtures
07/01/2004DE10260085A1 Selective extraction of 2-keto-L-gulonic acid from polar solution, especially reaction mixture obtained in preparing ascorbic acid by lactonization, using mixture of tertiary amine and polar organic diluent
07/01/2004DE10257785A1 Isophthalsäurederivate Isophthalic acid derivatives
07/01/2004DE10231890B4 Verfahren zur Abtrennung von Ascorbinsäure aus einem polaren, Ascorbinsäure und 2-Keto-L-gulonsäure enthaltenden Lösungsmittel Process for the separation of ascorbic acid from a polar, ascorbic acid and 2-keto-L-gulonic acid solvent containing
06/2004
06/30/2004EP1432734A1 Cytokine receptor
06/30/2004EP1432687A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
06/30/2004EP1432680A1 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
06/30/2004EP1432453A1 Stilbene derivatives and their use for binding and imaging amyloid plaques
06/30/2004EP1289978A4 Novel electron acceptors for polymeric thin film waveguide media
06/30/2004EP0809629B1 2-phenyl-substituted heterocyclic 1,3-ketonols as herbicides and pesticides
06/30/2004CN1509279A Process for production of citalopram
06/30/2004CN1509278A N-phenyl-arylsulfonamide compound, drug comprising the compound as active ingredient, intermediate for the compound
06/30/2004CN1509169A Use of enantiomeric pure escitalopram
06/30/2004CN1508134A Anti-cance active substance of cyathocline purpurea and separating and purifying method thereof
06/30/2004CN1508133A Red-rooted salvia root anti-peptic ulcer effective site and preparing process thereof
06/30/2004CN1508129A Method for synthesizing pyrrole amides
06/30/2004CN1508114A Method for extracting active principle of diterpenes
06/30/2004CN1155562C New naphthalene compounds, process for their preparation and pharmaceutical compositions containing them
06/30/2004CN1155558C N-alkoxyalkyl-N, N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same
06/29/2004US6756501 Manufacture of 3-methyl-tetrahydrofuran from alpha-methylene-gamma-butyrolactone in a single step process
06/29/2004US6756500 Subjecting substituted alpha, omega-diene in presence of ruthenium, osmium or molybdenum homogeneous or heterogeneous catalyst to metathesis reaction in presence of ionic liquid to form cyclic compound
06/29/2004US6756404 Autoinducer compounds
06/29/2004US6756378 VLA-4 inhibitor compounds
06/24/2004WO2004052919A2 Peptide deformylase inhibitors
06/24/2004WO2004052872A1 Haloalkene compounds, process for their production and pesticides containing them
06/24/2004WO2004052844A1 Prodrugs of gaba analogs, compositions and uses thereof
06/24/2004WO2004052841A1 Carbidopa prodrugs and uses thereof
06/24/2004WO2004052839A1 Isophtalic acid derivatives
06/24/2004WO2004052836A1 Method for preparing 4-hydroxyisoleucine diastereoisomers and enantiomers and derivatives thereof
06/24/2004WO2004052816A1 Dihalo-allyloxy-phenol derivatives having pesticidal activity
06/24/2004WO2004026224A3 Process for preparing prostaglandin derivatives and starting materials for the same
06/24/2004WO2003090690A3 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
06/24/2004WO2003064617A9 Pestalotiopsis microsporia isolates and compounds derived therefrom
06/24/2004WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/24/2004US20040122242 Ruthenium-molybdenum catalyst for hydrogenation in aqueous solution
06/24/2004US20040122241 contacting 3-(hydroxymethyl)tetrahydrofuran or 3-formyltetrahydrofuran with a secondary alcohol in the presence of a hydrous zirconia catalyst
06/24/2004US20040122125 Lactone compounds as novel photoinitiators
06/24/2004US20040122102 compounds are potent ocular hypotensives, and are suitable for the management of glaucoma; they also are smooth muscle relaxants with broad application in systemic hypertensive and pulmonary diseases, gastrointestinal, reproduction disorders etc
06/24/2004US20040122098 useful for treating conditions which arise from or are exacerbated by angiogenesis and also for treating cancer
06/24/2004US20040122091 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
06/24/2004US20040122085 Compounds based on 1-oxoisochroman or - phthalan such as phyllodulcin and hydrangenol; food, beverage and feed additives; alcohol abuse
06/24/2004US20040122050 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors
06/24/2004US20040122040 Bicyclic guanidine derivatives and therapeutic uses thereof
06/24/2004US20040122007 1-aryl-2-hydroxyethyl amides as potassium channel openers
06/24/2004US20040121995 such as trifluoromethanesulfonic acid, N-[4-(2,5-difluorophenyl)-4-(6-trifluoromethyl-pyridine-3-sulfonyl)-cyclohexyl]-amide; for treatment/prevention of Alzheimer's disease
06/24/2004US20040121985 Useful as restenosis inhibitors; for reducing the level of protein geranylgeranylation in mammalian cells
06/24/2004US20040121947 Compounds which inhibit beta-secretase activity and methods of use thereof
06/24/2004US20040121316 Method and compositions for identifying anti-HIV therapeutic compounds
06/24/2004US20040119052 Process for preparing alpha- and beta- methyl-gamma-butyrolactone and 3-methyltetrahydrofuran
06/24/2004DE10258314A1 New alkoxyimino-substituted biphenylcarboxamide derivatives, useful as pesticides, antimicrobials, herbicides and antimycotics, also their new intermediates
06/24/2004DE10249324A1 Polymerisationsfähige bicyclische Cyclopropanderivate und deren Verwendung zur Herstellung von Dentalmaterialien Polymerizable bicyclic cyclopropane derivatives and their use for the preparation of dental materials
06/24/2004CA2507669A1 Method for preparing 4-hydroxyisoleucine diastereoisomers and enantiomers and derivatives thereof
06/23/2004EP1431296A1 Process for preparing alpha- and beta-methyl-gamma-butyrolactone and 3-methyltetrahydrofuran
06/23/2004EP1431295A1 Process for the preparation of 3-methyltetrahydrofuran
06/23/2004EP1430044A1 Process for the preparation of citalopram
06/23/2004EP1430043A1 Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists
06/23/2004EP1430042A2 Bicyclic heterocycles as rxr ligands
06/23/2004EP1430028A2 Aromatic and heteroaromatic acid halides for synthesizing polyamides
06/23/2004EP1429765A2 Inhibitors of histone deacetylase
06/23/2004EP1076644B1 N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
06/23/2004CN1507442A Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors
06/23/2004CN1507440A Continuous process for producing L-ascorbic acid
06/23/2004CN1507439A Process for the production of 5-benzyl-3-furfuryl alcohol
06/23/2004CN1507427A Indane compounds with negative dielectric anisotropy
06/23/2004CN1506358A Benzofuran derivative and its prepn and use
06/23/2004CN1506357A Process of preparing coarse vitamin C with glulconic acid
06/23/2004CN1154651C Method for separating analogous organic compounds
06/23/2004CN1154634C 2-phenyl-substituted heterocyclic 1,3-keonols as herbicides and pesticides
06/23/2004CN1154483C Use of amines to produce drugs for preventing tumour cell proliferation
06/22/2004US6753433 Citalopram; halogenating 5-cyanophthalide to form 2-(halomethyl)-4-cyanobenzoyl halide; reaction with p-fluorophenyl- borane or metal halide; reacting with 3-(dimethylamino)propylmetal halide
06/22/2004US6753429 1,4-disubstituted benzenes as insecticides
06/22/2004US6753426 Antiinflammatory agents; autoimmune disease
06/22/2004US6753346 CETP activity inhibitor
06/22/2004CA2308555C Process for producing 3-methyltetrahydrofuran, and process for producing an intermediate thereof
06/17/2004WO2004051217A2 Process for synthesis bis-aryl diamidoxime compounds
06/17/2004WO2004050795A2 Antioxidant-functionalized polymers
06/17/2004WO2004050667A1 Transition metal complex having diphosphine complex as ligand
06/17/2004WO2004050662A1 Single pot conversion of artemisinin into arteether